298 related articles for article (PubMed ID: 15675573)
21. New treatment strategies for aggressive lymphoma.
Younes A
Semin Oncol; 2004 Dec; 31(6 Suppl 15):10-3. PubMed ID: 15726533
[TBL] [Abstract][Full Text] [Related]
22. [New therapy of patients with malignant lymphoma using G-CSF].
Asano S
Nihon Naika Gakkai Zasshi; 1994 Jun; 83(6):924-7. PubMed ID: 7525813
[No Abstract] [Full Text] [Related]
23. Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies.
Basaran G; Basaran M; Onat H
J Clin Oncol; 2005 May; 23(13):3161-2; author reply 3162-3. PubMed ID: 15860887
[No Abstract] [Full Text] [Related]
24. [The standard treatments for patients with hematological malignancies in Japan].
Ishizawa K
Gan To Kagaku Ryoho; 2007 May; 34(5):709-12. PubMed ID: 17496442
[TBL] [Abstract][Full Text] [Related]
25. Current status of the treatment of HIV-associated lymphoma.
Kaplan LD
Clin Adv Hematol Oncol; 2004 Jan; 2(1):28-9. PubMed ID: 16163156
[No Abstract] [Full Text] [Related]
26. High-dose therapy for follicular lymphoma revisited: not if, but when?
Lister TA
J Clin Oncol; 2003 Nov; 21(21):3894-6. PubMed ID: 14517186
[No Abstract] [Full Text] [Related]
27. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
[TBL] [Abstract][Full Text] [Related]
28. The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma.
Villanueva ML; Vose JM
Clin Adv Hematol Oncol; 2006 Jul; 4(7):521-30. PubMed ID: 17147239
[TBL] [Abstract][Full Text] [Related]
29. Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients.
Park YH; Lee JJ; Ryu MH; Kim SY; Kim DH; Do YR; Lee KH; Oh SJ; Kim YK; Suh CW; Heo DS; Ryoo BY; Kim JK; Song HS; Lee WS; Kim HJ; Bang YJ; Yang SH; Sohn SK; Kang YK;
Ann Hematol; 2006 Apr; 85(4):257-62. PubMed ID: 16416337
[TBL] [Abstract][Full Text] [Related]
30. Composite lymphoma arising in the parotid gland: a case report.
Urano M; Mizoguchi Y; Nishio T; Abe M; Kuroda M; Saito S; Sakurai K
Auris Nasus Larynx; 2004 Mar; 31(1):89-93. PubMed ID: 15041061
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis and therapy of malignant thyroid lymphoma].
Kuma K; Matsuzuka F
Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1190-5. PubMed ID: 9379098
[No Abstract] [Full Text] [Related]
32. Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma.
Tam CS; Wolf M; Prince HM; Januszewicz EH; Westerman D; Lin KI; Carney D; Seymour JF
Cancer; 2006 Jun; 106(11):2412-20. PubMed ID: 16649223
[TBL] [Abstract][Full Text] [Related]
33. Dose-intense treatment of mantle cell lymphoma: can durable remission be achieved?
Dreyling M; Hiddemann W
Curr Opin Oncol; 2008 Sep; 20(5):487-94. PubMed ID: 19106649
[TBL] [Abstract][Full Text] [Related]
34. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
Abali H; Urün Y; Oksüzoğlu B; Budakoğlu B; Yildirim N; Güler T; Ozet G; Zengin N
Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
[TBL] [Abstract][Full Text] [Related]
35. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
Blayney DW; McGuire BW; Cruickshank SE; Johnson DH
Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
[TBL] [Abstract][Full Text] [Related]
36. [Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients].
Motomura S; Hashimoto C; Kodama F; Maruta A; Sakai R; Fujita H; Tomita N; Fujisawa S; Harano H; Koharazawa H; Fujimaki K; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 May; 46(5):350-7. PubMed ID: 16444968
[TBL] [Abstract][Full Text] [Related]
37. [A case of secondary malignant lymphoma of the urinary bladder].
Yokoyama M; Kobayashi T; Kubo Y; Kageyama Y; Kihara K
Hinyokika Kiyo; 2006 Apr; 52(4):285-7. PubMed ID: 16686357
[TBL] [Abstract][Full Text] [Related]
38. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in lymphoma without blood product support.
Sefcick A; Byrne JL; Russell NH
Bone Marrow Transplant; 2000 Nov; 26(10):1140-1. PubMed ID: 11108322
[No Abstract] [Full Text] [Related]
39. [Clinical treatment of MST-16 (Sobuzoxane) for malignant lymphoma].
Nakayama S; Yabe H; Nagai K
Gan To Kagaku Ryoho; 1991 Sep; 18(12):2179-82. PubMed ID: 1888191
[No Abstract] [Full Text] [Related]
40. [Coexistence of pure red cell aplasia and autoimmune hemolytic anemia occurring during remission of malignant lymphoma].
Toyota S; Nakamura N; Dan K
Rinsho Ketsueki; 2002 Jun; 43(6):493-5. PubMed ID: 12134708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
